This Hyperliquid Whale Sells $9M in HYPE, Still Undeterred
A prominent Hyperliquid holder dumped about $9 million worth of HYPE as the token surged to new highs, underscoring a...
Deciding between broad market and sector funds depends on diversification needs and risk tolerance. This guide compares outcomes and helps you decide.
28,547 articlesA prominent Hyperliquid holder dumped about $9 million worth of HYPE as the token surged to new highs, underscoring a...
These software stocks have surged as geopolitical tensions rise, outpacing broader tech gains and signaling a shift i...
Pfizer is stepping into a high-stakes arena long led by Lilly and Novo Nordisk. This article analyzes what pfizer's w...
A new ETF aims to monetize the price swings of Rocket Lab and other space names by selling weekly put spreads to fund...
What if a philanthropic powerhouse holds a large share of its stock in just a few mega-cap names? This article explor...
Small, nearly unknown biotech stocks can surge when their pipeline milestones hit. This guide breaks down how to spot...
Cathie Wood of Ark Invest has sparked big talk about where crypto could go. This article outlines a practical approac...
A notable fund trimmed a sizable healthcare stake by roughly $6.5 million as the stock soared and revenue grew. Here’...
As AI workloads surge, memory players like MICRON TECHNOLOGY (MU) stand at a crossroads. This guide breaks down how g...
Oracle stock drop today? sent shockwaves through the tech arena as investors weigh cloud strategy and AI momentum. Th...
When a top analyst starts coverage on GE Vernova, it can spark a notable move in the stock. This piece breaks down wh...
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...